
InfuSystem Holdings INFU
€ 7.33
-1.24%
Quartalsbericht 2026-Q1
hinzugefügt 08.05.2026
InfuSystem Holdings EV/EBITDA 2011-2026 | INFU
EV/EBITDA Jährlich InfuSystem Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.24 | 10.1 | 14.1 | 13.1 | 15.8 | 40.6 | 23.8 | 18.9 | 29 | 16.9 | 7.7 | 6.86 | 9.9 | 13.1 | 18 | 21 | 5.48 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 40.6 | 5.48 | 15.9 |
EV/EBITDA anderer Aktien in der Medizinische Instrumente
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
34.6 | $ 60.79 | 0.68 % | $ 12.1 B | ||
|
Atrion Corporation
ATRI
|
25.8 | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
-38.7 | $ 115.17 | 0.88 % | $ 3.69 B | ||
|
Luminex Corporation
LMNX
|
15.9 | - | - | $ 1.75 B | ||
|
ICU Medical
ICUI
|
13.8 | $ 121.75 | -1.01 % | $ 3 B | ||
|
Repro Med Systems
KRMD
|
-93.1 | $ 3.89 | -2.26 % | $ 180 M | ||
|
Akers Biosciences, Inc.
AKER
|
-0.0238 | - | -9.52 % | $ 20.6 M | ||
|
Intuitive Surgical
ISRG
|
49.3 | $ 426.62 | -0.34 % | $ 152 B | ||
|
LeMaitre Vascular
LMAT
|
34.9 | $ 99.14 | -0.36 % | $ 2.24 B | ||
|
Alcon
ALC
|
72.7 | $ 64.53 | 0.8 % | $ 40.4 B | ||
|
Masimo Corporation
MASI
|
40.8 | $ 178.4 | 0.03 % | $ 9.51 B | ||
|
Antares Pharma, Inc.
ATRS
|
44 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
24.9 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
6.47 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
14.8 | - | -0.05 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
0.307 | - | - | $ 28.6 M | ||
|
Envista Holdings Corporation
NVST
|
10.9 | $ 23.88 | 0.13 % | $ 4.01 B | ||
|
Varian Medical Systems, Inc.
VAR
|
252 | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
-1.06 | $ 6.3 | -2.02 % | $ 53.4 K | ||
|
Haemonetics Corporation
HAE
|
12.9 | $ 56.86 | -0.4 % | $ 2.86 B | ||
|
STAAR Surgical Company
STAA
|
-10.7 | $ 31.88 | -0.42 % | $ 1.58 B | ||
|
STERIS plc
STE
|
29.7 | $ 215.75 | -0.17 % | $ 21.3 B | ||
|
Teleflex Incorporated
TFX
|
46.4 | $ 130.11 | -0.13 % | $ 5.81 B | ||
|
Isoray
ISR
|
-0.266 | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
-908 | $ 142.59 | 0.3 % | $ 6.91 B | ||
|
Microbot Medical
MBOT
|
-8.17 | $ 1.92 | 3.51 % | $ 87.9 M | ||
|
Milestone Scientific
MLSS
|
-4.93 | $ 0.34 | -0.15 % | $ 27.9 M | ||
|
Merit Medical Systems
MMSI
|
25 | $ 62.51 | -0.08 % | $ 3.7 B | ||
|
Utah Medical Products
UTMD
|
9.56 | $ 63.24 | -0.72 % | $ 205 M | ||
|
West Pharmaceutical Services
WST
|
33.1 | $ 302.94 | 0.92 % | $ 21.9 B | ||
|
Pulse Biosciences
PLSE
|
-21.4 | $ 24.97 | -7.88 % | $ 1.68 B | ||
|
DENTSPLY SIRONA
XRAY
|
11.9 | $ 10.04 | -3.6 % | $ 2 B | ||
|
Retractable Technologies
RVP
|
3.35 | $ 0.69 | - | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
20.7 | $ 59.29 | 1.09 % | $ 195 M | ||
|
Predictive Oncology
POAI
|
1.29 | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
-68.9 | $ 20.77 | -1.36 % | $ 992 M | ||
|
Stereotaxis
STXS
|
-8.89 | $ 1.88 | -3.34 % | $ 171 M | ||
|
Baxter International
BAX
|
24.7 | $ 17.56 | -1.29 % | $ 9.01 B | ||
|
ResMed
RMD
|
35.2 | $ 204.64 | 1.03 % | $ 29.9 B | ||
|
AtriCure
ATRC
|
587 | $ 28.64 | 1.72 % | $ 1.37 B | ||
|
Harvard Bioscience
HBIO
|
-1.68 | $ 5.48 | -0.69 % | $ 243 M | ||
|
NeuroMetrix
NURO
|
-2.11 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
-102 | $ 11.01 | -0.18 % | $ 450 M | ||
|
Becton, Dickinson and Company
BDX
|
11 | $ 143.69 | -0.57 % | $ 41.3 B | ||
|
Nephros
NEPH
|
24.3 | $ 3.21 | -3.94 % | $ 34.1 M | ||
|
OraSure Technologies
OSUR
|
-1.59 | $ 3.04 | 3.05 % | $ 223 M | ||
|
Repligen Corporation
RGEN
|
2.12 | $ 105.54 | 2.09 % | $ 5.93 M |